Alcresta Therapeutics

Creating point-of-care, enzyme-based medical nutrition products to improve fat absorption

Alcresta is a specialty pharmaceuticals company focusing on discovering and developing a new generation of enzyme-based products that improve digestion and absorption of important nutrients. The company's lead program is a point-of-care, enzyme-based product that improves the bioavailability of long chain fatty acids (such as DHA, EPA, and AA) for patients with impaired pancreatic output. Compromised pancreatic function is a complication of many diseases such as cystic fibrosis, chronic pancreatitis, and cancer as well as developmental immaturity, and Alcresta's products are aimed at meeting the nutritional needs of these patients.

Year of Investment



Life Sciences


Specialty Pharmaceuticals


Newton, Massachusetts